Propionic Acid

Propionic Acid

SCHEMBL4153953

CCC(=O)O.O=c1[nH]c2ccc(S(=O)(=O)Nc3ccc(O)cc3)cc2c2cc[nH]c12

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.55
GAA P10253 1/20 0.55
AR P10275 1/20 0.55
PDE3A Q14432 1/20 0.47
BRAF P15056 3/20 0.45
POLB P06746 2/20 0.44
GFER P55789 1/20 0.44
MAPT P10636 4/20 0.43
TP53 P04637 3/20 0.43
LMNA P02545 2/20 0.43
NAPEPLD Q6IQ20 1/20 0.43
BRD4 O60885 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4157631 0.92 BRAF (0.54) PKMGAAARPDE3ABRAF
Propionic Acid SCHEMBL4163285 0.92 PKM (0.54) PKMGAAARPDE3ABRAF
Propionic Acid SCHEMBL4160232 0.91 BRD4 (0.51) PKMGAAARPDE3ABRAF
Propionic Acid SCHEMBL4162959 0.91 BRAF (0.46) PKMGAAARPDE3ABRAF
Propionic Acid SCHEMBL4161141 0.91 BRAF (0.53) PKMGAAARPDE3ABRAF
Propionic Acid SCHEMBL4155348 0.90 PKM (0.44) PKMGAAARPDE3ABRAF
Propionic Acid SCHEMBL4163726 0.90 BRD4 (0.54) GAAPDE3APOLBGFERMAPT
Propionic Acid SCHEMBL4166797 0.88 PKM (0.43) PKMGAAARPDE3ABRAF
Propionic Acid SCHEMBL4167132 0.87 BRAF (0.44) PKMGAAARPDE3ABRAF
Propionic Acid SCHEMBL4158062 0.87 MEN1 (0.60) POLBMAPTTP53LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 PKM 276/4885GAA 3035/4885AR 3401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.